Annual Debt To Equity
0.01
0.000.00%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual debt to equity ratio is 0.01, unchanged on December 31, 2023.
- During the last 3 years, MLTX annual debt to equity has risen by +1.30 (+100.78%).
- MLTX annual debt to equity is now at all-time high.
Performance
MLTX Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
0.01
0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly debt to equity ratio is 0.01, unchanged on September 30, 2024.
- Over the past year, MLTX quarterly debt to equity has stayed the same.
- MLTX quarterly debt to equity is now at all-time high.
Performance
MLTX Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
MLTX Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | +100.8% | +100.8% |
| 5 y5 years | +100.8% | +100.8% |
MLTX Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.8% | at high | +100.8% |
| 5 y | 5-year | at high | +100.8% | at high | +100.8% |
| alltime | all time | at high | +100.8% | at high | +100.8% |
MoonLake Immunotherapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 0.01(0.0%) |
| Jun 2024 | - | 0.01(0.0%) |
| Mar 2024 | - | 0.01(0.0%) |
| Dec 2023 | 0.01 | 0.01(>+9900.0%) |
| Sep 2023 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 0.00(-100.0%) |
| Mar 2023 | - | 0.01(0.0%) |
| Dec 2022 | 0.01(-100.8%) | 0.01(>+9900.0%) |
| Sep 2022 | - | 0.00(0.0%) |
| Jun 2022 | - | 0.00(-100.0%) |
| Dec 2021 | -1.29 | -1.29 |
FAQ
- What is MoonLake Immunotherapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual debt to equity year-on-year change?
- What is MoonLake Immunotherapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly debt to equity year-on-year change?
What is MoonLake Immunotherapeutics annual debt to equity ratio?
The current annual debt to equity of MLTX is 0.01
What is the all time high annual debt to equity for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual debt to equity ratio is 0.01
What is MoonLake Immunotherapeutics annual debt to equity year-on-year change?
Over the past year, MLTX annual debt to equity ratio has changed by 0.00 (0.00%)
What is MoonLake Immunotherapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of MLTX is 0.01
What is the all time high quarterly debt to equity for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly debt to equity ratio is 0.01
What is MoonLake Immunotherapeutics quarterly debt to equity year-on-year change?
Over the past year, MLTX quarterly debt to equity ratio has changed by 0.00 (0.00%)